arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

download Export Data

Inhibikase Therapeutics, Inc.

IKT

$1.44 ▼ -0.12 (-7.99%) at close

27 Visible periods

29 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

Inhibikase Therapeutics, Inc. faces fundamental challenges with weakness in Return on Common Equity (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $251.4M

Dividend Yield —

Revenue Growth None

Op. Margin None

ROIC -10.8% ↘

FCF / Share $-0.07 →

Trailing P/E —

Price / Book 1.2x

FCF Yield —

Debt / Equity —

info Valuation on last close. End-of-day price, Nov 5, 2026.

27-Year Financial Trajectory

Quarterly

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$0.00

— —

Net Income Profit after all expenses

$-16.38M

↓ -19.8% —

Operating Margin Operating profit as % of sales

-192.8%

↓ -3.4% —

FCF / Share Free cash flow per share

$-0.07

↓ -1.8% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Returns ↑

Cash Quality ↓

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 5 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Revenue Growth YoY (%)	—	—	—	—	—	—	—	N/M	N/M	N/M	-100.0% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1350%)	991.3% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+12292%)	1676.7% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+20859%)	40.2% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+402%)	3169.9% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+39523%)	-97.8% Weak → Weak Stable Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1322%)	-99.5% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1344%)	-96.7% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1309%)	-98.9% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-1336%)	771.7% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+9546%)	520.7% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+6409%)	419.7% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+5146%)	—	—	—	—	—
EPS Growth YoY (%)	0.0% Caution ↓ Caution Declining Year-over-year change in earnings per share Optimal: > 10%	33.3% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	N/M	80.0% Excellent → Excellent Stable Year-over-year change in earnings per share Optimal: > 10%	83.3% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	79.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	N/M	24.4% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	40.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	-356.2% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	77.5% Excellent ↑ Excellent Improving Year-over-year change in earnings per share Optimal: > 10%	18.9% Good ↑ Good Improving Year-over-year change in earnings per share Optimal: > 10%	-0.9% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	11.1% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	-410.0% Weak ↑ Weak Improving Year-over-year change in earnings per share Optimal: > 10%	-488.9% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	-400.0% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	—	—	—	—	—	—	—	—	—	—
Net Income Growth YoY (%)	-19.8% Weak ↑ Weak Improving Year-over-year change in net income	-19.8% Weak ↑ Weak Improving Year-over-year change in net income	-5.0% Weak ↑ Weak Improving Year-over-year change in net income	-194.2% Weak → Weak Stable Year-over-year change in net income	-194.2% Weak ↓ Weak Declining Year-over-year change in net income	-194.2% Weak ↓ Weak Declining Year-over-year change in net income	-190.4% Weak ↓ Weak Declining Year-over-year change in net income	-3.8% Weak ↓ Weak Declining Year-over-year change in net income	-3.8% Weak ↓ Weak Declining Year-over-year change in net income	-3.8% Weak ↓ Weak Declining Year-over-year change in net income	2.4% Caution ↓ Caution Declining Year-over-year change in net income	3.5% Caution ↓ Caution Declining Year-over-year change in net income	3.5% Caution ↑ Caution Improving Year-over-year change in net income	3.5% Caution ↑ Caution Improving Year-over-year change in net income	15.1% Good ↑ Good Improving Year-over-year change in net income	-76.0% Weak ↑ Weak Improving Year-over-year change in net income	-76.0% Weak ↑ Weak Improving Year-over-year change in net income	-76.0% Weak ↑ Weak Improving Year-over-year change in net income	-317.4% Weak ↑ Weak Improving Year-over-year change in net income	-381.7% Weak → Weak Stable Year-over-year change in net income	-381.7% Weak Weak Year-over-year change in net income	-381.7% Weak Weak Year-over-year change in net income	—	—	—	—	—
FCF Growth YoY (%)	—	-52.2% Weak Weak Year-over-year change in free cash flow	—	—	—	92.5% Excellent Excellent Year-over-year change in free cash flow	—	—	—	-180.9% Weak Weak Year-over-year change in free cash flow	—	—	—	-39.1% Weak ↑ Weak Improving Year-over-year change in free cash flow	—	-1580.6% Weak Weak Year-over-year change in free cash flow	-197.3% Weak Weak Year-over-year change in free cash flow	—	—	—	—	—	—	—	—	—	—
Revenue CAGR 3Y (%)	—	—	—	—	—	—	—	—	—	—	-98.2% Weak ↓ Weak Declining Compound annual revenue growth over 3 years	28.3% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	-19.1% Weak Weak Compound annual revenue growth over 3 years	-38.0% Weak Weak Compound annual revenue growth over 3 years	—	—	—	—	—	—	—	—	—	—	—	—	—

💰 Are margins durable? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Operating Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-192.8% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1386%)	-186.6% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1344%)	—	—	-188.5% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1357%)	-199.4% Weak Weak Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1429%)	—
Profit Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-193.5% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1712%)	-187.4% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1662%)	—	—	-249.3% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-2178%)	-202.2% Weak Weak Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-1785%)	—
FCF Margin (%) (%)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-311.5% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	-279.6% Weak ↓ Weak Declining Free cash flow as a percentage of revenue Optimal: > 10%	—	200.4% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	-1.3% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	-94.3% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—
FCF / Net Income (x)	0.76x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.74x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.59x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.77x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	—	0.30x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.44x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—	—	0.83x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	0.82x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—	—	1.33x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.83x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.23x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.94x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	0.85x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.81x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	0.77x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	1.61x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	1.49x Good ↑ Good Improving Free cash flow relative to reported net income Optimal: > 1x	0.78x Caution ↑ Caution Improving Free cash flow relative to reported net income Optimal: > 1x	-0.14x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	0.01x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.47x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Return on Invested Capital (%)	-10.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-8.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-6.3% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-13.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-13.5% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	867.7% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-78.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-55.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-31.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-25.1% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-25.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-14.7% Weak → Weak Stable Return earned on debt + equity capital invested Optimal: > 10%	-16.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-14.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-12.4% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.8% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-10.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-8.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-4.4% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-22.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-9.7% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	10.2% Good ↑ Good Improving Return earned on debt + equity capital invested Optimal: > 10%	6.8% Caution Caution Return earned on debt + equity capital invested Optimal: > 10%	9.1% Fair Fair Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-12.9% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-10.3% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-7.6% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-16.0% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-12.2% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-15.5% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-13.1% Weak ↑ Weak Improving Operating profit relative to total assets Optimal: > 10%	-133.1% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-57.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-43.2% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-30.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-26.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-27.8% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-16.7% Weak Weak Operating profit relative to total assets Optimal: > 10%	-17.4% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	-11.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	-22.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	-8.1% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—	—	—
Return on Common Equity (%) (%)	-10.7% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-171%)	-9.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-165%)	-7.4% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-149%)	-18.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-225%)	-17.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-214%)	-16.0% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-206%)	-12.8% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-185%)	—	-91.2% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-708%)	-68.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-557%)	-38.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-354%)	-29.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-299%)	-23.0% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-253%)	-17.7% Weak → Weak Stable Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-218%)	-20.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-236%)	-18.5% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-223%)	-15.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-205%)	-13.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-191%)	-13.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-187%)	-6.1% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-141%)	-5.6% Weak ↑ Weak Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-137%)	-32.8% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-319%)	-12.3% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-182%)	10.7% Fair ↓ Fair Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-29%)	11.3% Fair Fair Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-24%)	11.6% Fair Fair Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-22%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Debt to Equity (x)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	0.15x Excellent Excellent Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-74%)	—	—	—	—	—
Interest Coverage (x)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-4769.37x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-273.10x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-28477.96x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-336.50x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-222.54x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-168.21x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-96.33x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	-52.08x Weak Weak Operating income divided by interest expense Optimal: > 5x	-72.73x Weak Weak Operating income divided by interest expense Optimal: > 5x	—
Net Debt (USD)	—	—	$-178.80M	—	—	—	$-97.50M	—	—	—	$-9.20M	—	—	—	$-7.19M	—	—	—	$-40.75M	—	—	$1.24M	—	—	—	—	—
Debt / EBITDA (x)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	-0.47x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—	—	—

📊 What does each share earn? 6 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Revenue per Share (USD)	$0.00	$0.00	—	$0.00	$0.00	$0.00	—	$0.00	$0.00	$0.00	—	$0.01	$0.02	$0.00	—	$0.00	$0.00	$0.00	—	$0.01	$0.11	—	—	—	—	—	—
Basic EPS, GAAP (USD)	$-0.11	$-0.10	$-0.09	$-0.13	$-0.11	$-0.15	$0.87	$-0.65	$-0.66	$-0.73	$-0.23	$-0.86	$-1.11	$-0.16	$-1.02	$-1.06	$-1.10	$-0.18	$-0.20	$-0.18	$-0.22	—	—	—	—	—	—
Free Cash Flow per Share (USD)	$-0.07	$-0.07	—	$-0.12	—	$-0.05	—	—	—	$-0.61	—	—	—	$-0.22	—	$-1.35	$-1.03	$-0.16	—	$-0.08	$-0.35	—	—	—	—	—	—
Book Value per Share (USD)	$1.16	$1.27	$1.31	$0.97	$1.07	$1.15	$1.37	$-0.07	$0.71	$1.05	$1.77	$2.80	$3.68	$0.82	$4.98	$5.95	$6.98	$1.35	$1.53	$1.72	$3.84	$0.80	$0.97	—	—	—	—
Tangible Book Value per Share (USD)	$1.16	$1.27	$1.31	$0.97	$1.07	$1.15	$1.37	$-0.07	$0.71	$1.05	$1.77	$2.80	$3.68	$0.82	$4.98	$5.95	$6.98	$1.35	$1.53	$1.72	$3.84	$0.80	$0.97	—	—	—	—
Basic Weighted Avg Shares (shares)	174.57M	172.31M	—	90.05M	90.01M	89.54M	—	8.88M	7.54M	6.34M	—	5.34M	5.23M	27.51M	—	4.22M	4.22M	25.21M	—	25.14M	12.24M	—	—	—	—	—	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Working Capital (USD)	$152.08M	$166.46M	$171.81M	$71.84M	$80.00M	$85.61M	$94.72M	$-717.36K	$4.90M	$6.57M	$10.77M	$14.81M	$19.25M	$24.96M	$20.68M	—	—	—	$38.42M	—	—	$8.28M	—	—	—	—	—
LT Debt (USD)	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	$1.24M	—	—	—	—	—
Total Equity (USD)	$153.33M	$167.62M	$172.90M	$72.90M	$80.05M	$85.73M	$94.87M	$-530.59K	$5.10M	$6.78M	$10.98M	$15.02M	$19.46M	$25.32M	$21.04M	$25.14M	$29.50M	$34.01M	$38.42M	$43.16M	$47.05M	$8.04M	$9.78M	$-5.13M	$-4.83M	$-4.70M	$-4.49M

📋 What is driving earnings? 4 metrics

Metric	Q2 FY2026 Jun 30, 2026 10-Q ↗	Q1 FY2026 Mar 31, 2026 10-Q ↗	Q4 FY2025 Dec 31, 2025 10-K ↗	Q3 FY2025 Sep 30, 2025 10-Q ↗	Q2 FY2025 Jun 30, 2025 10-Q ↗	Q1 FY2025 Mar 31, 2025 10-Q ↗	Q4 FY2024 Dec 31, 2024 10-K ↗	Q3 FY2024 Sep 30, 2024 10-Q ↗	Q2 FY2024 Jun 30, 2024 10-Q ↗	Q1 FY2024 Mar 31, 2024 10-Q ↗	Q4 FY2023 Dec 31, 2023 10-K ↗	Q3 FY2023 Sep 30, 2023 10-Q ↗	Q2 FY2023 Jun 30, 2023 10-Q ↗	Q1 FY2023 Mar 31, 2023 10-Q ↗	Q4 FY2022 Dec 31, 2022 10-K ↗	Q3 FY2022 Sep 30, 2022 10-Q ↗	Q2 FY2022 Jun 30, 2022 10-Q ↗	Q1 FY2022 Mar 31, 2022 10-Q ↗	Q4 FY2021 Dec 31, 2021 10-K ↗	Q3 FY2021 Sep 30, 2021 10-Q ↗	Q2 FY2021 Jun 30, 2021 10-Q ↗	Q1 FY2021 Mar 31, 2021 10-Q ↗	Q4 FY2020 Dec 31, 2020 10-K ↗	Q3 FY2020 Sep 30, 2020 10-Q ↗	Q2 FY2020 Jun 30, 2020 10-Q ↗	Q1 FY2020 Mar 31, 2020 10-Q ↗	Q4 FY2019 Dec 31, 2019 10-K ↗
Sales/Revenue/Turnover (USD)	$0.00	$0.00	—	$0.00	$0.00	$0.00	—	$0.00	$0.00	$0.00	$1.00	$79.57K	$116.41K	$64.52K	$63.57K	$7.29K	$6.55K	$46.03K	$1.94K	$328.46K	$1.36M	$1.41M	$170.42K	$37.68K	$219.59K	$270.79K	—
Depreciation Expense (USD)	$0.00	$0.00	$0.00	$23.69K	$24.16K	$12.65K	$6.57K	$6.57K	$6.57K	$6.57K	$6.57K	$6.57K	$159.20K	$5.04K	$5.04K	$1.68K	$0.00	$0.00	$0.00	—	—	—	—	—	—	—	—
Net Income, GAAP (USD)	$-16.38M	$-16.38M	$-12.73M	$-13.68M	$-13.68M	$-13.68M	$-12.13M	$-4.65M	$-4.65M	$-4.65M	$-4.18M	$-4.48M	$-4.48M	$-4.48M	$-4.28M	$-4.64M	$-4.64M	$-4.64M	$-5.04M	$-2.64M	$-2.64M	$-2.64M	$-1.21M	$-547.44K	$-547.44K	$-547.44K	—
Operating Cash Flow (USD)	$-12.44M	$-12.06M	$-7.52M	$-10.59M	—	$-4.10M	$-5.35M	—	—	$-3.87M	$-3.44M	—	—	$-5.97M	$-3.56M	$-5.50M	$-4.36M	$-3.93M	$-4.10M	$-2.02M	$-4.25M	$-3.93M	$-946.53K	$75.52K	$-2.91K	$-255.43K	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 4 days ago 7 years · 27 quarters

Inhibikase Therapeutics, Inc.

Analytical Summary

27-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare IKT with peers